Osteopore Ltd. (AU:OSX) has released an update.
Osteopore Ltd., a leader in regenerative medicine with innovations in 3D-printed bone implants, has updated its capital raising efforts with a second replacement prospectus following the closure of a A$3 million entitlement offer. This new prospectus includes additional regulatory and expansion information, outlines the use of raised funds, and grants applicants withdrawal rights with refund instructions. The company plans to reconcile and announce the results of the fundraising on April 5th, 2024.
For further insights into AU:OSX stock, check out TipRanks’ Stock Analysis page.
